These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


374 related items for PubMed ID: 20393367

  • 1. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.
    Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, Perreault S.
    Med Care; 2010 May; 48(5):418-25. PubMed ID: 20393367
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of statin adherence on cerebrovascular disease in primary prevention.
    Perreault S, Ellia L, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L.
    Am J Med; 2009 Jul; 122(7):647-55. PubMed ID: 19559167
    [Abstract] [Full Text] [Related]

  • 5. Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan.
    Wu PH, Yang CY, Yao ZL, Lin WZ, Wu LW, Chang CC.
    Am J Hypertens; 2010 Feb; 23(2):155-60. PubMed ID: 19927135
    [Abstract] [Full Text] [Related]

  • 6. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG.
    Circulation; 2009 Oct 20; 120(16):1598-605. PubMed ID: 19805653
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved].
    Grosso G, Raciti T, Marventano S, Romeo I, Mistretta A.
    Ann Ig; 2011 Oct 20; 23(2):173-84. PubMed ID: 21770233
    [Abstract] [Full Text] [Related]

  • 10. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
    Esposito D, Bagchi AD, Verdier JM, Bencio DS, Kim MS.
    Am J Manag Care; 2009 Jul 20; 15(7):437-45. PubMed ID: 19589011
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive medication adherence and subsequent healthcare utilization and costs.
    Pittman DG, Tao Z, Chen W, Stettin GD.
    Am J Manag Care; 2010 Aug 20; 16(8):568-76. PubMed ID: 20712390
    [Abstract] [Full Text] [Related]

  • 12. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.
    Balu S, Simko RJ, Quimbo RM, Cziraky MJ.
    Curr Med Res Opin; 2009 Nov 20; 25(11):2765-75. PubMed ID: 19785511
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD, Friedman JY, Velazquez EJ, Gnanasakthy A, Califf RM, Schulman KA.
    Am Heart J; 2004 Jul 20; 148(1):122-8. PubMed ID: 15215801
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.